CoChat
Sign Up
Cited by 130

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The Angiopoietin-like Proteins ANGPTL3 and ANGPTL4 Inhibit Lipoprotein Lipase Activity through Distinct Mechanisms

Shan, Lu, Yu, Xuan-Chuan, Liu, Ziye, Hu, Yi, Sturgis, Lydia T., Miranda, Maricar L., Liu, Qingyun·2009·Journal of Biological Chemistry
DOI 10.1074/jbc.m808477200
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m808477200

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ANGPTL3 reduced the catalytic activity of LPL, but did not increase the rate of self-inactivation.

    “They found that ANGPTL3 reduced the catalytic activity of LPL, but did not increase the rate of self-inactivation.”

    From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [55]

    The Results report that ANGPTL3 inhibited LPL’s initial catalytic activity. They also say it did not *significantly* accelerate inactivation beyond LPL’s self-inactivation, while noting a limited ability to accelerate inactivation; the categorical claim that it did not increase the rate omits that qualification. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

  • Multiple laboratories have confirmed the ability of ANGPTL4 to inhibit LPL.

    “In the years since, multiple laboratories have confirmed the ability of ANGPTL4 to inhibit LPL (49–55).”

    From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [55]

  • LPL inhibition by ANGPTL3 was distinct from ANGPTL4-mediated LPL inactivation.

    “Shan et al. (55) found that LPL inhibition by ANGPTL3 was distinct from ANGPTL4-mediated LPL inactivation.”

    From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [55]

  • ANGPTL3 inhibition of LPL was reversible and heparin protected LPL from inhibition.

    “They also determined that ANGPTL3 inhibition of LPL was reversible and that heparin protected LPL from inhibition (55).”

    From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [55]

  • Several studies have reported that ANGPTL3 is a less potent inhibitor than ANGPTL4.

    “In fact, several studies have reported that ANGPTL3 is a less potent inhibitor than ANGPTL4 (54, 55, 60, 133, 136),”

    From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [55]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Braun, 1992, Biochemical J., 287, 337, 10.1042/bj2870337 · DOI
  2. Merkel, 2002, J. Lipid Res., 43, 1997, 10.1194/jlr.R200015-JLR200 · DOI
  3. Beigneux, 2007, Cell Metab., 5, 279, 10.1016/j.cmet.2007.02.002 · DOI · Paper page
  4. Young, 2007, Curr. Opin. Lipidol., 18, 389, 10.1097/MOL.0b013e3281527914 · DOI
  5. Goldberg, 1996, J. Lipid Res., 37, 693, 10.1016/S0022-2275(20)37569-6 · DOI
  6. Bergo, 2002, J. Biol. Chem., 277, 11927, 10.1074/jbc.M200325200 · DOI · Paper page
  7. Wu, 2003, J. Biol. Chem., 278, 11925, 10.1074/jbc.M212736200 · DOI
  8. Emmerich, 1992, J. Biol. Chem., 267, 4161, 10.1016/S0021-9258(19)50642-1 · DOI
  9. Kobayashi, 2002, Eur. J. Biochem., 269, 4701, 10.1046/j.1432-1033.2002.03179.x · DOI
  10. Rip, 2006, Arterioscler. Thromb. Vasc. Biol., 26, 1236, 10.1161/01.ATV.0000219283.10832.43 · DOI · Paper page
  11. Li, 2007, Curr. Opin. Lipidol., 18, 597, 10.1097/MOL.0b013e3282efa4e1 · DOI
  12. Lookene, 2004, J. Biol. Chem., 279, 49964, 10.1074/jbc.M407419200 · DOI
  13. Koishi, 2002, Nat. Genet., 30, 151, 10.1038/ng814 · DOI · Paper page
  14. Shimizugawa, 2002, J. Biol. Chem., 277, 33742, 10.1074/jbc.M203215200 · DOI · Paper page
  15. Sukonina, 2006, Proc. Natl. Acad. Sci. U. S. A, 103, 17450, 10.1073/pnas.0604026103 · DOI · Paper page
  16. Desai, 2007, Proc. Natl. Acad. Sci. U. S. A, 104, 11766, 10.1073/pnas.0705041104 · DOI · Paper page
  17. Ono, 2003, J. Biol. Chem., 278, 41804, 10.1074/jbc.M302861200 · DOI · Paper page
  18. Yoshida, 2002, J. Lipid Res., 43, 1770, 10.1194/jlr.C200010-JLR200 · DOI · Paper page
  19. Mandard, 2006, J. Biol. Chem., 281, 934, 10.1074/jbc.M506519200 · DOI · Paper page
  20. Lichtenstein, 2007, Arterioscler. Thromb. Vasc. Biol., 27, 2420, 10.1161/ATVBAHA.107.151894 · DOI · Paper page
  21. Ando, 2003, J. Lipid Res., 44, 1216, 10.1194/jlr.M300031-JLR200 · DOI
  22. Shimamura, 2007, Arterioscler. Thromb. Vasc. Biol., 27, 366, 10.1161/01.ATV.0000252827.51626.89 · DOI · Paper page
  23. Romeo, 2007, Nat. Genet., 39, 513, 10.1038/ng1984 · DOI · Paper page
  24. Hatsuda, 2007, J. Vasc. Res., 44, 61, 10.1159/000098153 · DOI
  25. Ge, 2004, J. Lipid Res., 45, 2071, 10.1194/jlr.M400138-JLR200 · DOI · Paper page
  26. Osborne, 1985, Biochemistry, 24, 5606, 10.1021/bi00341a048 · DOI
  27. Wong, 1997, Proc. Natl. Acad. Sci. U. S. A, 94, 5594, 10.1073/pnas.94.11.5594 · DOI
  28. Ge, 2005, J. Lipid Res., 46, 1484, 10.1194/jlr.M500005-JLR200 · DOI · Paper page
  29. Potenz, 1996, Methods Enzymol., 263, 319, 10.1016/S0076-6879(96)63023-7 · DOI
  30. Panteghini, 2001, Ann. Clin. Biochem., 38, 365, 10.1258/0004563011900876 · DOI
  31. Corbalan-Garcia, 1993, Biochim. Biophys. Acta, 1203, 45, 10.1016/0167-4838(93)90034-O · DOI
  32. Teruel, 1986, Biochim. Biophys. Acta, 869, 8, 10.1016/0167-4838(86)90303-1 · DOI
  33. Copeland, 2005, Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists
  34. van Tilbeurgh, 1994, J. Biol. Chem., 269, 4626, 10.1016/S0021-9258(17)41822-9 · DOI
  35. Ge, 2004, J. Biol. Chem., 279, 2038, 10.1074/jbc.M307583200 · DOI · Paper page
  36. Graca, 2005, Vet. Clin. Pathol., 34, 39, 10.1111/j.1939-165X.2005.tb00007.x · DOI

Cited by

Sorted by citations

Metadata

Authors
Shan, L., Yu, X.-C., Liu, Z., Hu, Y., Sturgis, L. T., Miranda, M. L., & Liu, Q.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2009-01
Volume
284
Issue
3
Pages
1419-1424
ISSN
0021-9258
DOI
10.1074/jbc.m808477200
Cited by
130
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review